Intelligence · Clinical Development
Pipeline search results
Programs matching “Astra” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 467 pipeline programs matching "Astra" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Rilvegostomig, Rilvegostomig
AstraZeneca AB
Advanced Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, stage III unresectable Non-small Cell Lung Cancer (Protocol Parts A-B), stage IV Non-small Cell Lung Cancer (Protocol Parts A-E).
1 trial -
SAKK 08/23
Ningbo Cancer Hospital
Metastatic castration-resistant prostate cancer
1 trial -
SAVANNAH
AstraZeneca AB
EGFRm+ and MET+, Locally Advanced or Metastatic Non Small Cell Lung Cancer.
1 trial -
SAVANNAH/D5084C0007
AstraZeneca AB
EGFRm+ and MET+, Locally Advanced or Metastatic Non Small Cell Lung Cancer
1 trial -
SPRINKLE D1346C00004
AstraZeneca AB
Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)
1 trial -
SRF617
Arcus Biosciences
Metastatic Castration-resistant Prostate Cancer
1 trial -
SX-682
United Therapeutics Europe Ltd
Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
1 trial -
Saruparib
AstraZeneca AB
Advanced/Recurrent Ovarian cancer
1 trial -
TD001
Wuhan Createrna Science and Technology Co., Ltd
Metastatic castration-resistant prostate cancer
1 trial -
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostatic Neoplasms, Castration-Resistant
1 trial -
Testosterone Enanthate 100 MG/ML Injectable Solution
Hospital Authority, Hong Kong
Castration-resistant Prostate Cancer
1 trial -
Testosterone cypionate
United Therapeutics Europe Ltd
Castration Resistant Metastatic Prostate Cancer
1 trial -
Tozorakimab
AstraZeneca
Asthma
1 trial -
Trastuzumab deruxtecan
AstraZeneca
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
1 trial -
Volrustomig
AstraZeneca
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)
1 trial -
YERVOY for castration-resistant prostate c…
Disc Medicine
castration-resistant prostate cancer
1 trial -
ZEAL-UNLOCK
AstraZeneca AB
Cirrhosis of the liver is a condition in which the liver is scarred and damaged
1 trial -
osimertinib
AstraZeneca
Carcinoma
1 trial -
D798VC00001
AstraZeneca AB
Colorectal cancer
1 trial -
20180146
Amgen
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1 trial -
22049
Bayer Australia Ltd
Advanced metastatic castration-resistant prostate cancer with prostate specific membrane antigen (PSMA) expression
1 trial -
67652000PCR1001
Janssen-Cilag International N.V.
Metastatic castration-resistant prostate cancer (mCRPC)
1 trial -
70218902EDI1001
Janssen-Cilag International N.V.
Metastatic Castration-Resistant Prostate Cancer
1 trial -
78278343PCR1001
Janssen-Cilag International N.V.
Metastatic castration-resistant prostate cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.